PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call Transcript

Jan 17, 2023 / 09:30PM GMT
Release Date Price: €6.82 (+5.32%)
Operator

Greetings, and welcome to the PAVmed and Lucid Diagnostics Strategic Business Update. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Parks, Vice President of Investor Relations. Thank you. You may begin.

Michael Parks

Thank you, Doug. Good afternoon, everyone. Thank you for participating in today's joint business update call. The press release announcing our strategic business update is available on both PAVmed and Lucid websites. Please take a moment to read the disclaimer about forward-looking statements in the press release. The strategic business update, press release and the conference call, those include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and description of these and other important risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot